| Hang Seng Index | 19.970 HKD | -0.590 | -2.870% | 1.30B | 26.13B | 20.564 (-2.888%) HKD as at 2024/11/11 | | |
| Hang Seng China Enterprises | 72.500 HKD | -2.360 | -3.153% | 88.40M | 6.46B | 74.978 (-3.305%) HKD as at 2024/11/11 | | |
| Hang Seng TECH Index | 4.368 HKD | -0.196 | -4.294% | 1.13B | 5.00B | 4.567 (-4.357%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.250 HKD | -0.410 | -8.798% | 600.33M | 2.65B | 4.690 (-9.380%) HKD as at 2024/11/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 3.270 HKD | +0.264 | +8.782% | 374.03M | 1.18B | 2.999 (+9.029%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 3.818 HKD | -0.242 | -5.961% | 262.35M | 1.02B | 4.062 (-6.016%) HKD as at 2024/11/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.786 HKD | +0.206 | +5.754% | 177.62M | 656.95M | 3.576 (+5.864%) HKD as at 2024/11/11 | | |
| CSI 300 | 45.200 HKD | -0.500 | -1.094% | 8.71M | 396.48M | 46.062 (-1.872%) HKD as at 2024/11/11 | | |
| Hang Seng TECH Index | 9.360 HKD | -0.470 | -4.781% | 34.39M | 328.78M | 9.792 (-4.416%) HKD as at 2024/11/11 | | |
| HSI ESG Enhanced Index (net total return index) | 41.960 HKD | -0.880 | -2.054% | 6.21M | 261.35M | 43.117 (-2.684%) HKD as at 2024/11/11 | | |
| FTSE China A50 | 14.160 HKD | -0.240 | -1.667% | 14.27M | 204.07M | 14.396 (-1.641%) HKD as at 2024/11/11 | | |
| Hang Seng TECH Index | 4.436 HKD | -0.184 | -3.983% | 31.75M | 142.74M | 4.627 (-4.118%) HKD as at 2024/11/11 | | |
| MSCI China | 21.060 HKD | -0.620 | -2.860% | 6.69M | 141.37M | 21.735 (-3.105%) HKD as at 2024/11/11 | | |
| Hang Seng TECH Index | 5.635 HKD | -0.240 | -4.085% | 23.52M | 138.13M | 5.899 (-4.480%) HKD as at 2024/11/11 | | |
| FTSE China A50 | 13.340 HKD | -0.210 | -1.550% | 7.05M | 94.99M | 13.631 (-2.133%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.116 HKD | -0.180 | -4.190% | 22.49M | 93.46M | 4.315 (-4.621%) HKD as at 2024/11/11 | | |
| CME Bitcoin Futures | 32.560 HKD | +2.900 | +9.777% | 2.87M | 93.27M | 31.699 (+2.716%) HKD as at 2024/11/11 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 11.110 HKD | +1.010 | +10.000% | 6.27M | 69.50M | 10.023 (+10.842%) HKD as at 2024/11/11 | | |
| London Gold Fixing Price | 1,863.000 HKD | -51.000 | -2.665% | 31.91K | 59.87M | 1,885.768 (-1.207%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 2.372 HKD | -0.164 | -6.467% | 21.36M | 51.38M | 2.529 (-6.212%) HKD as at 2024/11/11 | | |
| CSI 300 | 41.400 CNY | +0.020 | +0.048% | 1.15M | 49.33M | 42.669 (-2.974%) CNY as at 2024/11/11 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 69.320 HKD | +6.200 | +9.823% | 473.16K | 32.66M | 58.944 (+17.603%) HKD as at 2024/11/08 | | |
| MSCI Japan 100% Hedged to USD Index | 21.060 HKD | +0.060 | +0.286% | 1.49M | 31.37M | 20.984 (+0.362%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 4.932 HKD | -0.088 | -1.753% | 5.67M | 28.75M | 5.071 (-2.741%) HKD as at 2024/11/11 | | |
| Hang Seng High Dividend Yield | 23.120 HKD | -0.680 | -2.857% | 1.02M | 23.70M | 23.762 (-2.700%) HKD as at 2024/11/11 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.530 HKD | -0.290 | -2.953% | 2.24M | 21.66M | 9.890 (-3.635%) HKD as at 2024/11/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 11.300 HKD | -0.640 | -5.360% | 1.83M | 20.91M | 11.412 (-0.983%) HKD as at 2024/11/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.015 HKD | +0.047 | +0.946% | 3.90M | 19.55M | 5.005 (+0.194%) HKD as at 2024/11/11 | | |
| CSI 300 | 29.300 HKD | -0.540 | -1.810% | 655.60K | 19.42M | 29.830 (-1.775%) HKD as at 2024/11/11 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 9.240 HKD | -0.075 | -0.805% | 1.59M | 14.65M | 9.414 (-1.845%) HKD as at 2024/11/11 | | |